Search form

Home
LoginSubscribe
  • Home
  • Country Intelligence
  • Industry Directory
  • Offsets / IC
  • Tenders
    • Haiti(0/week)
    • Guyana(0/week)
    • Honduras(0/week)
    • Jamaica(0/week)
    • Netherlands Antilles(0/week)
    • View all (0/week)
  • News
    • United States(1111/week)
    • Manufacturing(552/week)
    • Technology(996/week)
    • Energy(442/week)
    • Other Manufacturing(371/week)
  • Events
  • About us
    • Who we are
    • Our People
    • Partners
    • Contact us
  • LinkedIn
  • Login
  • Twitter
  • Register
  • Home
  • News

Abl

May 08, 2024
Former Superintendent of the Year Joins Abl's Advisory Board
May 13, 2020
Equity Advocate and Edtech Executive Tapped to Lead Creator of Popular K-12 Scheduling Software
May 07, 2020
Ascentage Pharma's Core Drug Candidate HQP1351 Granted Fast Track Designation by the US FDA, Marking Another Milestone in Its Development
Dec 10, 2019
Ascentage Pharma Releases Updated Data of its Novel BCR-ABL Inhibitor, HQP1351, in an Oral Presentation Nominated for "Best of ASH"
Nov 14, 2019
Ascentage Pharma to Release Updated Data of its Novel, Third-Generation BCR-ABL Inhibitor, HQP1351, in Chinese Chronic Myeloid Leukemia Patients in an Oral Presentation at the 61st American Society of Hematology Annual Meeting
Oct 02, 2019
Cepheid Receives FDA Clearance for Xpert® BCR-ABL Ultra Test
Sep 03, 2019
Selvita to Present at Upcoming Conferences in September
Jul 21, 2019
Ascentage Pharma to Initiate Phase Ib Study of HQP1351 in Tyrosine Kinase Inhibitors -resistant Chronic Myeloid Leukemia Patients in the US
Feb 20, 2019
Data Interoperability Simplifies Scheduling Process, Supports Seamless Implementation of College and Career Pathways
Nov 21, 2018
Ascentage Pharma to Present New Clinical Data at the ASH 2018 Annual Meeting
Nov 19, 2018
ABL Expands GMP Viral Vector Manufacturing Capacity with State-of-the-Art Facility Acquisition in Lyon, France
Nov 12, 2018
ABL, Inc. Announces Appointment of Jarlath Keating as President and Chief Executive Officer
Sep 04, 2018
Genoptix Launches FDA-Authorized BCR-ABL MRDx® TFR Monitoring Test for Patients with Chronic Myeloid Leukemia on Tasigna®(nilotinib)
Jul 30, 2018
ABL Bio and I-Mab Biopharma Announce Global Collaboration on Innovative Bispecific Antibodies
Jul 26, 2018
I-Mab Biopharma and ABL Bio Announce Global Collaboration on Innovative Bispecific Antibodies
Jul 19, 2018
$2.2m Grant Helps Schools Adopt New Time Strategies
Jun 04, 2018
ABL, Inc. Announces Hiring of Marykay Marchigiani as Chief Financial Officer
May 23, 2018
School Leaders Nationwide Can Apply for Fall 2018 Cohort of Next Generation Master Scheduling Platform
May 03, 2018
San Antonio Schools Tap Master Scheduling Platform to Develop Schedules Tailored to Individual Student Needs
Mar 01, 2018
Cleveland-Cliffs Amends and Improves its ABL Facility
  •  
  • Page 1
  • ››

Latest News

Jul 25, 2025

Penetron expands production in India to keep pace with market growth

Jul 25, 2025

Bureau Veritas Expands its Footprint in New Strongholds Through Acquisitions in Cybersecurity, Nuclear and...

Jul 25, 2025

Energy Dome Inks a Strategic Commercial Agreement with Google

Jul 25, 2025

Kyocera Launches Revolutionary TPA Series Thermal Printhead

Jul 25, 2025

Straits Orthopaedics Expands Global Footprint with Acquisition of U.S.-Based Medin Technologies,...

Jul 25, 2025

Faraday Future Hosts Successful Capitol Hill Club Reception Showcasing Commitment to American Manufacturing...

Jul 25, 2025

Liberty Energy Inc. Announces Second Quarter 2025 Financial and Operational Results

Jul 25, 2025

Kodiak Gas Services Announces Quarterly Dividend

View all News

Agenda

30
September
PortugalTroia, Portugal
Seabed Security, 30 September - 01 October 2025, Troia, Portugal
Seabed Security | 30 September - 01 October 2025 | Troia, Portugal Defence iQ Announces Inaugural Seabed Security...
23
September
United KingdomLondon, UK
Countering Explosive Threat & Demining conference, September 23 - 24, 2025, London, UK
Countering Explosive Threat & Demining conference | September 23 - 24, 2025 | London, UK The Countering Explosive...
View All Events

SUBSCRIBE

to Epicos.com
Please register in order to have access to personalized daily information on world-wide A&D industry developments and business opportunities.
Subscribe

REGISTER

for Epicos.com Newsletter
Sign up for our free newsletters and receive twice a week news and intelligence regarding the Aerospace & Defence Industry, meticulously selected by our editorial team.
Sign Up
Home
  • SIGN UP FOR NEWSLETTER
  • NEWSLETTER ARCHIVE
  • ADVERTISE WITH US
  • CONTACT US
  • PRIVACY POLICY
  • INFORMATION SECURITY POLICY
© 2025 EPICOS
Made by Wedia